We propose a transparent framework for CMS to implement Medicare drug price negotiation in a manner that results in credible, evidence-based decision-making, with a core purpose of aligning the price with the value that the targeted drugs offer.
We propose a transparent framework for CMS to implement Medicare drug price negotiation in a manner that results in credible, evidence-based decision-making, with a core purpose of aligning the price with the value that the targeted drugs offer.